"President Trump signed an executive order entitled 'Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States' establishing tariffs of 100% on imports of patented pharmaceuticals and their ingredients to be levied in the next 120 days against 17 drugmakers including AbbVie, Bristol Myers Squibb, and Gilead."
"The Federal Circuit ruled that the omission of a co-inventor from a patent invalidates those patent claims if inventorship cannot be corrected, emphasizing the importance of proper inventorship in patent law."
"The U.S. Patent and Trademark Office (USPTO) Director John Squires vacated a series of patent validity challenges filed by TikTok for failure to prove that Chinese government entities are not real-parties-in-interest, highlighting the complexities of international patent disputes."
"Dina Kallay, the U.S. Department of Justice's Deputy Assistant AG for Antitrust, stated that the DOJ prefers standards developed with FRAND obligations over other consortia, indicating a strategic approach to antitrust regulations in technology."
President Trump signed an executive order imposing 100% tariffs on imports of patented pharmaceuticals and their ingredients. This order targets 17 drugmakers, including AbbVie and Gilead. The Federal Circuit ruled that omitting a co-inventor invalidates patent claims if inventorship cannot be corrected. The USPTO vacated patent validity challenges from TikTok due to insufficient proof regarding Chinese government entities. SpaceX is negotiating with Saudi Arabia's Public Investment Fund for a $5 billion stake retention. Meta Platforms announced 200 layoffs, and China's IP agency is enhancing collaboration with Hungary and Finland.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]